Fabrice Carrat to Nucleosides
This is a "connection" page, showing publications Fabrice Carrat has written about Nucleosides.
Connection Strength
0.034
-
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. Lancet Gastroenterol Hepatol. 2017 03; 2(3):177-188.
Score: 0.034